CD30‐positive cutaneous T‐cell lymphoma with concurrent solid tumour

Summary Extranodal CD30+ T‐cell lymphomas seldom carry classical t(2;5) translocation and are usually anaplastic large cell lymphoma kinase protein negative. They cover a wide spectrum of histological and clinical behaviour. The prognosis of CD30+ cutaneous T‐cell lymphoma (CTCL) is good in the absence of nodal primary or disseminated disease. These lesions can undergo spontaneous regression, and overlap with the group of lesions of lymphomatoid papulosis. Although an increased incidence of solid tumours has been reported in patients with CD30+ non‐Hodgkin lymphoma of the skin, reports of concurrent malignancies are rare in CD30+ CTCL. We report two patients with CD30+ CTCL who, respectively, had concurrent disseminated gastric carcinoma and bilateral ovarian teratoma. Despite an aggressive clinical and histological appearance, both cases ran favourable clinical courses. The CTCL responded completely to chemotherapy in one patient, who eventually succumbed to gastric cancer. In the other patient, lesions regressed spontaneously after bilateral oophorectomy. A possible relationship between the lymphoma and the solid tumours is discussed.

[1]  M. Cooperberg,et al.  Ki-1 anaplastic large-cell lymphoma occurring at the site of ileocolonic anastomosis in a patient treated surgically for colonic adenocarcinoma: case report and review of the literature. , 2001, Annals of diagnostic pathology.

[2]  S. Leung,et al.  Synchronous gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma in association with Helicobacter pylori infection: comparing reported cases between the East and West , 2001, American Journal of Gastroenterology.

[3]  R. Dummer,et al.  Allelic deletion at 9p21-22 in primary cutaneous CD30(+) large cell lymphoma. , 2000, The Journal of investigative dermatology.

[4]  C. Meijer,et al.  Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment , 2000 .

[5]  I. Shah,et al.  Concurrent primary large cell lymphoma and carcinoid tumor of the small bowel. , 2000, American journal of clinical pathology.

[6]  S. Ansell,et al.  Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. , 1999, The American journal of surgical pathology.

[7]  M. Kajimura,et al.  Case Report: G-CSF-Producing Gastric Anaplastic Large Cell Lymphoma Complicating Esophageal Cancer , 1999, Digestive Diseases and Sciences.

[8]  C. Hsieh,et al.  Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis , 1999, Cancer.

[9]  T. Greiner,et al.  Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. , 1999, Blood.

[10]  A. Ormerod,et al.  Primary cutaneous CD30 (Ki‐1)‐positive anaplastic large cell lymphoma associated with renal cell carcinoma , 1999, The British journal of dermatology.

[11]  S. Pileri,et al.  ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. , 1998, The American journal of pathology.

[12]  A. Rosenwald,et al.  Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: Infrequent detection of the t(2;5) in extranodal lymphomas , 1998, Genes, chromosomes & cancer.

[13]  X. Troussard,et al.  SPECTRUM OF CD30 LYMPHOPROLIFERATIVE DISEASES FROM LYMPHOMATOID PAPULOSIS TO ANAPLASTIC LARGE CELL LYMPHOMA , 1996, International journal of dermatology.

[14]  A. Chott,et al.  The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. , 1996, The Journal of investigative dermatology.

[15]  F. Herrmann,et al.  CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells. , 1996, Leukemia & lymphoma.

[16]  F. Cavalli,et al.  High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  M. Paulli,et al.  CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Knoll,et al.  Cytogenetic findings in regressing skin lesions of lymphomatoid papulosis. , 1995, Cancer genetics and cytogenetics.

[19]  H. Frierson,et al.  Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study. , 1995, The American journal of pathology.

[20]  T. Whiteside,et al.  Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. , 1991, Cancer research.

[21]  R. Dobson,et al.  British Association of Dermatologists , 2014 .

[22]  C. Meijer,et al.  Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. , 2000, Blood.

[23]  R. Gascoyne,et al.  Second malignancies in patients with hairy cell leukemia in british columbia: a 20-year experience. , 1998, Blood.

[24]  A. Bernheim,et al.  High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. , 1996, Blood.